Q2 2021 Holdings
Filed 2021-08-12 | 9 holdings | $47.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $46.9M | 1,798,163 | 99.3% |
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $87.3K | 3,931,818 | 0.2% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $66.2K | 2,765,314 | 0.1% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $64.0K | 2,747,433 | 0.1% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $62.3K | 2,960,046 | 0.1% |
| Praxis Precision Medicines, Inc. | Common Stock | 74006W108 | $53.7K | 2,939,329 | 0.1% |
| Oyster Point Pharma, Inc. | Common Stock | 69242L106 | $11.3K | 658,468 | 0.0% |
| Homology Medicines, Inc. | Common Stock | 438083107 | $5.6K | 770,845 | 0.0% |
| Assembly Biosciences, Inc. | Common Stock | 045396108 | $1.5K | 384,635 | 0.0% |